Perinatal outcomes associated with the use of glargine during pregnancy

Diabetic Medicine

Volumn 25, Issue 8, 2008, Pages 993-996

  Di Cianni, G ^a,i   Torlone, E ^b   Lencioni, C ^a   Bonomo, M ^c   Di Benedetto, A ^d   Napoli, A ^e   Vitacolonna, E ^f   Mannino, D ^g   Lapolla, A ^h  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

^g Department of Endocrinology and Diabetology   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ CISANELLO HOSPITAL   (Italy)

Author keywords

Birthweight; Congenital malformations; Diabetes; Insulin glargine; Pregnancy

Indexed keywords

INSULIN GLARGINE;

ABORTION; ADULT; ARTICLE; BIRTH WEIGHT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GLYCEMIC CONTROL; HUMAN; MACROSOMIA; MAJOR CLINICAL STUDY; NEWBORN MORBIDITY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREVALENCE;

ABNORMALITIES, DRUG-INDUCED; ADULT; BIRTH WEIGHT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FETAL MACROSOMIA; HUMANS; HYPOGLYCEMIC AGENTS; INFANT MORTALITY; INFANT, NEWBORN; INSULIN; ITALY; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 48149109623     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02485.x     Document Type: Article

References (25)

1. Owens DR, Zinnan B, Bolli GB. Insulin today and beyond. Lancet 2001 358 : 739 746.
2. Temple R, Aldrige V, Greenwood R, Heypurn B, Sampson M, Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in Type 1 diabetes: a population-based study. Br Med J 2002 325 : 1275 1276.
3. Manderson JG, Patterson CC, Hadden DR, Traub Al, Ennis C, McCance DR. Preprandial versus postprandial blood glucose monitoring in Type 1 diabetic pregnancy: a randomized controlled clinical trial. Am J Obstet Gynecol 2003 189 : 507 512.
4. Slieker LJ, Brooke GS, Di Marchi R, Flora D, Green LK, Hoffmann JA. Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-1 receptor more than for the insulin receptor. Diabetologia 1997 40 : 54 61.
5. Devlin JT, Hothershall L, Wilkis JL. Use of insulin glargine during pregnancy in a Type 1 diabetic woman. Diabetes Care 2002 25 : 1095 1096.
6. Holstein A, Plaschke A, Egberts EH. Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes. Diabet Med 2003 20 : 779 780.
7. Di Cianni G, Volpe L, Lencioni C, Chatzianagnostou K, Cuccuru I, Ghio A et al. Use of insulin glargine during the first week of pregnancy in five Type 1 diabetic women. Diabetes Care 2005 28 : 982 983.
8. Dolci M, Mori M, Baccetti F. Use of glargine before and during pregnancy in a woman with Type 1 diabetes and Addison's disease. Diabetes Care 2005 28 : 2084 2085.
9. Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K. Use of insulin glargine during pregnancy in seven Type 1 diabetic women. Diabetes Care 2005 28 : 2594 2595.
10. Torlone E, Gennarini A, Ricci NB, Bolli GB. Successful use of insulin glargine during entire pregnancy until delivery in six Type 1 diabetic women. Eur J Obstet Gynecol 2007 132 : 238 239.
11. Price N, Bartelett C, Gilmer MD. Use of insulin glargine during pregnancy: a case-control pilot study. Br J Obstet Gynaecol 2007 11 : 453 457.
12. Föyhönen-Alho M, Tapani R, Saltevo J, Ekbald U, Kaaja RJ. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand 2007 86 : 1171 1174.
13. Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with Type 1 diabetes. Diabet Med 2008 25 : 165 169.
14. Parazzini F, Cortinovis I, Bortulus R, Fedele L, Recarli A. Weight at birth by gestational age in Italy. Hum Reprod 1995 10 : 1852 1863.
15. Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005 192 : 989 997.
16. Lechat MF, Dolk H. Registries of congenital anomalies: EUROCAT. Environ Health Perspect 1993 101 : 153 157.
17. Johansen KS, Hodd M. Quality development in perinatal care - the OBSQID project. Int J Gynaecol Obstet 1999 64 : 167 172.
18. Casson IF, Clarke CA, Howard CV, McKendrik O, Pennycook S, Pharao PO et al. Outcome of pregnancy in insulin-dependent diabetic women: result of a five-year population cohort study. Br Med J 1997 315 : 275 278.
19. Penney GC, Mair G, Pearson DW. Outcomes of pregnancies in women with Type 1 diabetes in Scotland: a national population-based study. Br J Obstet Gynaecol 2003 110 : 315 318.
20. Diabetes Pregnancy Group France. French multicenter survey of outcome of pregnancy in women with pre-gestational diabetes. Diabetes Care 2003 26 : 2990 2993.
21. Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with Type 1 diabetes: nationwide prospective study in the Netherlands. Br J Obstet Gynaecol 2004 328 : 915 917.
22. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JD, Moeller M et al. Outcomes in Type 1 diabetic pregnancies. A nationwide population-based study. Diabetes Care 2004 27 : 2819 2823.
23. Macintosh MCM, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D et al. Perinatal mortality and congenital anomalies in babies of women with Type 1 or Type 2 diabetes in England, Wales and Northern Ireland: a population-based study. Br Med J 2006 333 : 177 180.
24. Lapolla A, Dalfrà MG, Di Cianni G, Bonomo M, Parretti E, Mello G for the Scientific Committee of the GISOD Group. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis 2008 18 : 291 297.
25. Langer O. Fetal macrosomia: etiologic factors. Clin Obstet Gynecol 2000 43 : 283 297.